Rambam Health Care Campus
Haifa, 31906, Israel
Location status: Recruiting
NCT Number: NCT07689357
The goal of this clinical trial is to learn if a shorter duration of cervical ripening balloon (CRB) placement can reduce the time to delivery in pregnant women undergoing induction of labor.
The main questions it aims to answer are:
Does placing the cervical ripening balloon for 3 hours or less result in a shorter interval from insertion to delivery compared to the standard 12-hour placement?
Does a shorter 3-hour balloon placement lead to better pregnancy outcomes, fewer complications, and lower maternal discomfort?
Researchers will compare a group of participants who have the balloon removed after 3 hours to a control group who have the balloon removed after 12 hours to see if the shorter duration decreases the overall time to delivery.
Participants will:
Sign an informed consent and be randomized into one of the two groups (3 hours vs. 12 hours).
Undergo the standard procedure of a double-lumen Cook cervical ripening balloon insertion.
Have the balloon removed after approximately 3 hours or 12 hours depending on their assigned group.
Proceed with amniotomy or Pitocin use at the discretion of the labor and delivery physician.
Complete a Birth Satisfaction Scale questionnaire and have their maternal and neonatal health outcomes tracked from the hospital's database.
Interested in participating?
Request Info18 year–45 year
Female
Interventional
Not applicable
Haifa, 31906, Israel
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Use of a transcervical balloon catheter for pre-induction cervical ripening. The catheter is inserted through the cervix, the balloon(s) inflated with sterile saline. The device remains in place for 3 hours.
Use of a transcervical balloon catheter for pre-induction cervical ripening. The catheter is inserted through the cervix, the balloon(s) inflated with sterile saline. The device remains in place for 12 hours.
Time frame: From the time of balloon insertion up to delivery (approximately 48 hours).
The time interval (in hours) from the successful insertion of the cervical ripening balloon to the time of fetal delivery (whether vaginal or cesarean section).
Time frame: At the time of delivery.
The rates of successful vaginal deliveries, instrumental deliveries (vacuum), and cesarean deliveries between the two groups.
Time frame: From balloon insertion up to delivery, assessed up to 48 hours after balloon insertion.
The duration (in hours) from balloon insertion to the onset of the active phase of labor, and the duration of the second stage of labor.
Time frame: From balloon insertion up to 48 hours postpartum.
Composite rate of maternal complications including chorioamnionitis, postpartum hemorrhage (PPH, defined as estimated blood loss greater than 1000 mL), need for blood transfusion, maternal fever during or after delivery, and obstetric anal sphincter injuries (OASIS).
Time frame: From birth up to newborn discharge or 7 days of life.
Composite rate of neonatal outcomes including birthweight, Apgar scores at 1 and 5 minutes (range 0-10; higher scores indicate better neonatal condition), neonatal umbilical cord pH, rates of respiratory complications, admission to the Neonatal Intensive Care Unit (NICU), and suspected or confirmed neonatal sepsis.
Time frame: From admission for induction up to hospital discharge (approximately 3-5 days).
The total length of maternal hospital stay (in days) from the day of admission for labor induction to the day of postpartum discharge.
Rambam Health Care Campus
Other
Comparison of Labor Induction With Cervical Ripening Balloon, 3 Hours vs 12 Hours Placement: a Randomized Controlled Trail
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07268118
Labor Induction
Boston, Massachusetts, United States
View Trial DetailsNCT07168187
Extra Amniotic Balloon, Labor Induction
Holon, Israel
View Trial DetailsNCT06580782
Dystocia, Female Urogenital Diseases and Pregnancy Complications
New York, United States
View Trial DetailsNCT07109258
Labor Induction
Cairo, Manial, Egypt
View Trial Details